Sino Biopharmaceutical Limited announced that the board of directors will hold a meeting on Tuesday, August 13, 2024 to mainly approve and disclose the unaudited interim results for the six months ended June 30, 2024, and consider whether to distribute interim dividends. The meeting will be chaired by the company secretary, Kai Nian Chen, and will be announced in Hong Kong on July 31, 2024. Currently, the board of directors of the company is composed of six executive directors and five independent non-executive directors.

Sino Biopharmaceutical Limited announced that the board of directors will hold a meeting on Tuesday, August 13, 2024 to mainly approve and disclose the unaudited interim results for the six months ended June 30, 2024, and consider whether to distribute interim dividends. The meeting will be chaired by the company secretary, Kai Nian Chen, and will be announced in Hong Kong on July 31, 2024. Currently, the board of directors of the company is composed of six executive directors and five independent non-executive directors.